Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.67 USD | -0.54% | +11.55% | -12.83% |
05-28 | CureVac, GSK Begin Dosing in Phase 2 Study for Seasonal Influenza Vaccine Candidate | MT |
05-23 | CureVac N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.83% | 827M | |
+54.05% | 63.85B | |
-2.02% | 41.83B | |
+40.01% | 40.47B | |
-10.22% | 27.17B | |
+13.42% | 26.52B | |
-21.60% | 18.69B | |
+2.89% | 12.73B | |
+22.40% | 12.11B | |
+27.49% | 12.07B |
- Stock Market
- Equities
- CVAC Stock
- News CureVac N.V.
- CureVac N : Plans To Sell Five Million Shares -- Stock Down 3% After-Hours